Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Sabrina Arena, Giorgio Corti, Erika Durinikova, et al.
Cancer Discovery
|
May 21, 2020
EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal Cancer
Vito Amodio, Rona Yaeger, Pamela Arcella, et al.
Nature Communications
|
August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells
Lisa Brunet, David Alexandre, Jiyoung Lee, et al.
Cancer Research
|
June 18, 2016
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Daniele Oddo, Erin M Sennott, Ludovic Barault, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2011
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells
Hiroyuki Konishi, Morassa Mohseni, Akina Tamaki, et al.
Cancer Discovery
|
October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Sabrina Arena, Giorgio Corti, Erika Durinikova, et al.
Cancer Discovery
|
May 21, 2020
EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal Cancer
Vito Amodio, Rona Yaeger, Pamela Arcella, et al.
Nature Communications
|
August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells
Lisa Brunet, David Alexandre, Jiyoung Lee, et al.
Cancer Research
|
June 18, 2016
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Daniele Oddo, Erin M Sennott, Ludovic Barault, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2011
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells
Hiroyuki Konishi, Morassa Mohseni, Akina Tamaki, et al.
Cancer Discovery
|
October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Page
of 6